185 related articles for article (PubMed ID: 27076627)
1. VEGF Potentiates GD3-Mediated Immunosuppression by Human Ovarian Cancer Cells.
Tiper IV; Temkin SM; Spiegel S; Goldblum SE; Giuntoli RL; Oelke M; Schneck JP; Webb TJ
Clin Cancer Res; 2016 Aug; 22(16):4249-58. PubMed ID: 27076627
[TBL] [Abstract][Full Text] [Related]
2. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.
Webb TJ; Giuntoli RL; Rogers O; Schneck J; Oelke M
Clin Cancer Res; 2008 Dec; 14(23):7652-8. PubMed ID: 19047090
[TBL] [Abstract][Full Text] [Related]
3. Molecular identification of GD3 as a suppressor of the innate immune response in ovarian cancer.
Webb TJ; Li X; Giuntoli RL; Lopez PH; Heuser C; Schnaar RL; Tsuji M; Kurts C; Oelke M; Schneck JP
Cancer Res; 2012 Aug; 72(15):3744-52. PubMed ID: 22649190
[TBL] [Abstract][Full Text] [Related]
4. Alterations in cellular metabolism modulate CD1d-mediated NKT-cell responses.
Webb TJ; Carey GB; East JE; Sun W; Bollino DR; Kimball AS; Brutkiewicz RR
Pathog Dis; 2016 Aug; 74(6):. PubMed ID: 27297969
[TBL] [Abstract][Full Text] [Related]
5. Cross-presentation of disialoganglioside GD3 to natural killer T cells.
Wu DY; Segal NH; Sidobre S; Kronenberg M; Chapman PB
J Exp Med; 2003 Jul; 198(1):173-81. PubMed ID: 12847141
[TBL] [Abstract][Full Text] [Related]
6. Fine specificity of natural killer T cells against GD3 ganglioside and identification of GM3 as an inhibitory natural killer T-cell ligand.
Park JE; Wu DY; Prendes M; Lu SX; Ragupathi G; Schrantz N; Chapman PB
Immunology; 2008 Jan; 123(1):145-55. PubMed ID: 18154620
[TBL] [Abstract][Full Text] [Related]
7. Avirulent Toxoplasma gondii generates therapeutic antitumor immunity by reversing immunosuppression in the ovarian cancer microenvironment.
Baird JR; Fox BA; Sanders KL; Lizotte PH; Cubillos-Ruiz JR; Scarlett UK; Rutkowski MR; Conejo-Garcia JR; Fiering S; Bzik DJ
Cancer Res; 2013 Jul; 73(13):3842-51. PubMed ID: 23704211
[TBL] [Abstract][Full Text] [Related]
8. Natural Killer T-cell Immunotherapy in Combination with Chemotherapy-Induced Immunogenic Cell Death Targets Metastatic Breast Cancer.
Gebremeskel S; Lobert L; Tanner K; Walker B; Oliphant T; Clarke LE; Dellaire G; Johnston B
Cancer Immunol Res; 2017 Dec; 5(12):1086-1097. PubMed ID: 29054890
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma.
Tiper IV; Webb TJ
Cancer Immunol Immunother; 2016 Nov; 65(11):1411-1421. PubMed ID: 27614429
[TBL] [Abstract][Full Text] [Related]
10. Connecting the dots: artificial antigen presenting cell-mediated modulation of natural killer T cells.
Sun W; Subrahmanyam PB; East JE; Webb TJ
J Interferon Cytokine Res; 2012 Nov; 32(11):505-16. PubMed ID: 23050947
[TBL] [Abstract][Full Text] [Related]
11. Tissue-Specific Roles of NKT Cells in Tumor Immunity.
Terabe M; Berzofsky JA
Front Immunol; 2018; 9():1838. PubMed ID: 30158927
[TBL] [Abstract][Full Text] [Related]
12. Positioning ganglioside D3 as an immunotherapeutic target in lymphangioleiomyomatosis.
Gilbert ER; Eby JM; Hammer AM; Klarquist J; Christensen DG; Barfuss AJ; Boissy RE; Picken MM; Love RB; Dilling DF; Le Poole IC
Am J Pathol; 2013 Jul; 183(1):226-34. PubMed ID: 23665200
[TBL] [Abstract][Full Text] [Related]
13. The characteristics of human NKT cells in lung cancer--CD1d independent cytotoxicity against lung cancer cells by NKT cells and decreased human NKT cell response in lung cancer patients.
Konishi J; Yamazaki K; Yokouchi H; Shinagawa N; Iwabuchi K; Nishimura M
Hum Immunol; 2004 Nov; 65(11):1377-88. PubMed ID: 15556688
[TBL] [Abstract][Full Text] [Related]
14. The restoration of myeloid-derived suppressor cells as functional antigen-presenting cells by NKT cell help and all-trans-retinoic acid treatment.
Lee JM; Seo JH; Kim YJ; Kim YS; Ko HJ; Kang CY
Int J Cancer; 2012 Aug; 131(3):741-51. PubMed ID: 21898392
[TBL] [Abstract][Full Text] [Related]
15. Antibody response to GD3 ganglioside is independent of NKT cells.
Park JE; Lu SX; Wu DY; Prendes M; Chapman PB
Cytotherapy; 2008; 10(1):38-44. PubMed ID: 18202973
[TBL] [Abstract][Full Text] [Related]
16. TNF-α production in NKT cell hybridoma is regulated by sphingosine-1-phosphate: implications for inflammation in atherosclerosis.
Ito S; Iwaki S; Kondo R; Satoh M; Iwabuchi K; Ohkawa R; Mishima Y; Yatomi Y; Furumoto T; Tsutsui H; Fujii S
Coron Artery Dis; 2014 Jun; 25(4):311-20. PubMed ID: 24448174
[TBL] [Abstract][Full Text] [Related]
17. SV40 T/t-common polypeptide inhibits angiogenesis and growth of HER2-overexpressing human ovarian cancer.
Hsueh SP; Hsu WB; Wen CC; Wang WB
Cancer Gene Ther; 2011 Dec; 18(12):859-70. PubMed ID: 21869825
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of glycolipid shedding rescues recognition of a CD1+ T cell lymphoma by natural killer T (NKT) cells.
Sriram V; Cho S; Li P; O'Donnell PW; Dunn C; Hayakawa K; Blum JS; Brutkiewicz RR
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8197-202. PubMed ID: 12060764
[TBL] [Abstract][Full Text] [Related]
19. NKT cells - New players in CAR cell immunotherapy?
Kriegsmann K; Kriegsmann M; von Bergwelt-Baildon M; Cremer M; Witzens-Harig M
Eur J Haematol; 2018 Dec; 101(6):750-757. PubMed ID: 30187578
[TBL] [Abstract][Full Text] [Related]
20. The CD1d-natural killer T cell axis in atherosclerosis.
Bondarenko S; Catapano AL; Norata GD
J Innate Immun; 2014; 6(1):3-12. PubMed ID: 23774666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
